How a Single Gene Mutation Drives Cognitive Impairment, Anxiety and Social Deficits
Summary
- A Molecular Cell study led by the University of Miami Miller School of Medicine’s Lluis Morey, Ph.D., reveals how mutations in key epigenetic regulators can derail early brain development to drive cognitive impairment, anxiety and social deficits.
- Neurodevelopmental disabilities now affect roughly one in six children in the United States, but information about what mutations do in the developing brain is scarce, even with genetic testing.
- By showing exactly how Polycomb mutations disrupt the sequence of events that produces healthy neurons and functional brains, Dr. Morey’s work provides a framework to interpret rare variants uncovered through genetic testing.
A newly published study published in Molecular Cell led by the University of Miami Miller School of Medicine’s Lluis Morey, Ph.D., reveals how rare mutations in key epigenetic regulators can derail early brain development to drive cognitive impairment, anxiety and social deficits.
Dr. Morey and Miller School colleagues Ramiro Verdun, Ph.D., Ramin Shiekhattar, Ph.D., and Katherina Walz, Ph.D., joined an international contingent of researchers to offer one of the clearest explanations to date for how disruptions in the Polycomb system contribute to neurodevelopmental disorders. Using advanced stem‑cell models, chromatin‑mapping technologies and genetically engineered pre-clinical models, the research team uncovered how a single mutation in the RNF2 gene reshapes the brain’s developmental trajectory long before birth.
“Our findings reveal a novel, epigenetic mechanism essential for neurodevelopmental integrity and brain function and demonstrate how mutations in Polycomb genes contribute to neurodevelopmental disorders,” said Dr. Morey, an associate professor in The Dr. John T. Macdonald Foundation Department of Human Genetics at the Miller School and the study’s senior author. “This study highlights the critical role of RNF2 mutations in advancing our understanding of intellectual disabilities.”
This study builds on years of foundational work by Dr. Morey, who uses experimental and computational technologies to determine how signaling pathways, transcription factors and chromatin regulators impact cancer-causing processes and studies mutations of genes encoding for Polycomb proteins essential for proper human development.
The Consequences of Gene Mutations
Neurodevelopmental disabilities now affect roughly one in six children in the United States. Yet, for many families, information about what that mutation actually does in the developing brain is scarce, even with genetic testing. Dr. Morey’s study helps close that gap by dissecting the molecular and cellular consequences of mutations in RING1 and RNF2, two genes that encode core components of Polycomb Repressive Complex 1 (PRC1), which keeps developmental genes switched on or off at the right time.
The team found several previously unknown mutations in RING1 and RNF2 in subjects with severe intellectual disabilities. By analyzing large genetics databases, they identified rare variants likely to disrupt how the PRC1 functions in the cell. Many occur in important, evolutionary conserved regions of the proteins, suggesting they may interfere with PRC1’s structure or activity across species, leading to abnormal gene regulation, impaired brain development and related cognitive and behavioral symptoms.
Honing in on RNF2 Mutations
For the study, Dr. Morey’s research team created pre-clinical models to study RNF2-R70H, a mutation they predicted and confirmed to interfere with PRC1’s function. The models featured embryonic stem cells carrying one mutant copy of RNF2. These stem cells allowed researchers to follow the earliest moments of a cell’s neural development.
These findings pave the way to develop strategies to improve brain function and reduce anxiety and sociability deficits driven by genetic mutations.
Dr. Lluis Morey
The researchers found that the R70H mutation disrupts the balance between PRC1 complexes, causing the mutant protein to associate with certain PRC1 complexes while displacing others. This shift alters the placement of key chemical tags that are normally required to regulate when neurodevelopmental genes turn on. Without the proper balance of these repressive marks, the genetic program that drives neural differentiation becomes scrambled.
Neural Development Derailed
When the mutant stem cells were guided to form self-renewing neural progenitor cells (NPCs) that are critical to brain development, they didn’t produce healthy neurons. Instead, the mutant NPCs catalyzed changes that prevented healthy brain cell development. Even experimentally turning the Wnt cell-signaling pathway back on could not rescue neuronal development, suggesting the mis‑routing occurs early and becomes irreversible.
“These findings suggest that a single-point mutation in a Polycomb gene is sufficient to rewire the transcriptional circuits necessary for the generation of functional neurons and pave the way to develop strategies to restore the epigenetic program to improve brain function and to reduce anxiety and sociability deficits driven by genetic mutations, ” Dr. Morey said.
What Happens in the Brain
The team then engineered pre-clinical models carrying the RNF2-R70H mutation. Models carrying two mutant copies did not survive, highlighting the essential role of RNF2 in development. But those with just one mutant copy, mirroring the situation in patients, provided a deeper look at brain structure and behavior.
These models showed:
• Changes in the circuits that support memory and emotional regulation
• Reduced neuronal density in key regions of the medial prefrontal cortex
• Abnormal social behavior, including reduced sociability and impaired recognition of social novelty
• Increased anxiety
A single‑cell analysis of adult brains revealed many neural cells remained in immature states, while glial and inflammatory cell types were over‑represented. Additionally, chromatin in these mutant cells was more compact than normal, restricting access to genes needed for proper brain cell maturation.
Given those findings, the study sheds new light on how Polycomb mutations can drive anxiety‑related behaviors and social difficulties. The disrupted PRC1 function led to altered neuronal architecture and weakened communication in key brain regions such as the prefrontal cortex and hippocampus. These molecular and structural changes translated into reduced sociability, poor recognition of social novelty and heightened anxiety‑like behaviors.
Looking Ahead
By showing exactly how Polycomb mutations disrupt the sequence of events that produces healthy neurons and functional brains, Dr. Morey’s work provides a framework to interpret rare variants uncovered through genetic testing. It also identifies potential therapeutic strategies centered on restoring proper Polycomb balance before critical developmental windows close.
Tags: anxiety, brain health, Cognitive impairment, Dr. John T. Macdonald Foundation Department of Human Genetics, Dr. Lluis Morey, epigenetics, gene editing, genetics